| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protagenic Therapeutics, Inc.\new (PTIX) has 0 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. PTIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2023 | Arrow Alexander K. | Chief Financial Officer | Buy | 8,000 | $0.81 | $6,480.00 | +21.2% | +21.7% | -31.0% | |
| May 18, 2022 | Arrow Alexander K. | Chief Financial Officer | Buy | 31,000 | $0.71 | $22,090.00 | +11.8% | -13.9% | -35.0% | |
| Apr 30, 2021 | Arrow Alexander K. | Chief Financial Officer | Buy | 2,000 | $2.29 | $4,580.00 | +0.8% | -1.3% | -63.8% | |
| Jun 17, 2016 | Armen Garo H49 | See Remarks | Buy | 60,211 | $1.25 | $75,263.75 | +1.4% | - | - |